Coronavirus (COVID-19) Collection
Constrictive pericarditis after SARS-CoV-2 vaccination: A case report
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a wide range of cardiovascular complications such as myocarditis, heart failure, arrhythmias, and venous thromboembolism (Chang et al., 2021). Although SARS-CoV-2 vaccination has been widely adopted to prevent the spread of COVID-19, vaccine-associated cardiovascular complications, such as myocarditis and pericarditis, have been reported (Bozkurt et al., 2021; Pepe et al., 2021).Immunological changes after COVID-19 vaccination in an HIV-positive patient
Concerns regarding the safety of vaccination in people living with HIV (PLWH) remain. Although no unusual adverse effects have been found after vaccination in PLWH, there are still not enough data to definitively prove whether or not infection with HIV raises the risk of adverse events after vaccination (Su et al., 2018). More than a year into the pandemic of coronavirus disease 2019 (COVID-19), several vaccines based on different platforms have been developed, although no effective vaccine for HIV has yet been employed, probably due to the different mechanisms of infection (Haynes, 2021) [Au?1].Combination of thrombolytic and immunosuppressive therapy for coronavirus disease 2019: A case report
A 68-year-old man presented to the emergency department of the General Hospital of Larissa complaining of a high-grade fever for the last 10 days. He had been taking a broad-spectrum antibiotic (clarithromycin) and an antiviral drug (oseltamivir) for 3 days prior to his admission, with no improvement. His medical history included hypertension and well-controlled type 2 diabetes mellitus, under treatment with oral anti-diabetic agents. Arterial blood gases revealed acute hypoxemic (type I) respiratory failure.
